Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of the radiosynthesis of the PSMA-targeting drugs [<sup>177</sup>Lu]Lu-P17-087 and [<sup>177</sup>Lu]Lu-P17-088 on the MiniLu™ automated module.

EJNMMI radiopharmacy and chemistry·2025
Same author

Head to head comparison of two PET/CT imaging agents, [<sup>18</sup>F]D3FSP ([<sup>18</sup>F]P16-129) and [<sup>18</sup>F]AV45, in patients with alzheimer's disease.

EJNMMI research·2025
Same author

First-in-human study of dosimetry, safety and efficacy for [<sup>177</sup>Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.

European journal of nuclear medicine and molecular imaging·2024
Same author

First-in-human study of D6-[<sup>18</sup>F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [<sup>18</sup>F]FP-(+)-DTBZ (AV-133).

EJNMMI radiopharmacy and chemistry·2024
Same author

Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study.

European journal of nuclear medicine and molecular imaging·2024
Same author

Theranostic Agent Targeting Bone Metastasis: A Novel [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu-DOTA-HBED-bisphosphonate.

Journal of medicinal chemistry·2024

Related Experiment Video

Updated: Jul 11, 2026

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
08:36

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

Simplifications in analyzing positron emission tomography data: effects on outcome measures.

Jean Logan1, David Alexoff, Aarti Kriplani

  • 1Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA. logan@bnl.gov

Nuclear Medicine and Biology
|October 9, 2007
PubMed
Summary

Eliminating invasive arterial blood sampling in positron emission tomography (PET) studies is crucial for clinical applications. This research explores methods to obtain accurate input functions and discusses alternatives to arterial sampling for improved radiotracer analysis.

More Related Videos

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images
09:21

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images

Published on: February 18, 2015

Related Experiment Videos

Last Updated: Jul 11, 2026

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
08:36

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner

Published on: June 7, 2024

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images
09:21

Human Brown Adipose Tissue Depots Automatically Segmented by Positron Emission Tomography/Computed Tomography and Registered Magnetic Resonance Images

Published on: February 18, 2015

Area of Science:

  • Nuclear Medicine
  • Radiochemistry
  • Pharmacokinetics

Background:

  • Positron emission tomography (PET) kinetic modeling typically requires an arterial input function (AIF) for accurate radiotracer quantification.
  • Arterial blood sampling is invasive and burdensome in clinical settings, necessitating alternative methods.
  • Shortened scanning protocols, like those used for F-18 fluorodeoxyglucose (FDG), also lead to information loss.

Purpose of the Study:

  • To investigate the impact of experimental conditions and population differences on PET input functions and outcome measures.
  • To analyze error propagation from metabolite measurements and the use of uptake ratios versus distribution volume ratios.
  • To evaluate the efficacy of reduced blood sampling strategies and explore alternatives to arterial sampling for PET studies.

Main Methods:

  • Analysis of dynamic PET data from human studies using [11C]raclopride and (S,S)-[11C]O-methyl reboxetine under baseline and drug-treated conditions.
  • Testing a two-blood-sample method to estimate plasma integrals for FDG metabolic rate calculations.
  • Investigating carotid artery measurements and potential wrist scanner technology as alternatives to direct arterial sampling.

Main Results:

  • Differences in experimental conditions can affect the input function and outcome measures in PET studies.
  • Errors in metabolite measurements and the use of uptake ratios introduce inaccuracies in quantification.
  • A two-point blood sampling method can estimate plasma integrals for FDG, and carotid artery measurements offer a potential alternative to arterial sampling.

Conclusions:

  • Minimizing or eliminating arterial blood sampling is essential for the clinical utility of PET radiotracers.
  • Developing non-invasive methods for input function estimation is critical for advancing PET applications.
  • Emerging technologies like wrist scanners hold promise for overcoming the limitations of current arterial sampling techniques.